80 Biggest Movers From Yesterday

Gainers

Avenue Therapeutics, Inc. ATXI jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday.
CTI BioPharma Corp. CTIC surged 63.2% to close at $3.10 after the company announced FDA accelerated approval of VONJO for the treatment of adult patients with myelofibrosis and thrombocytopenia.
GBS Inc. GBS gained 50% to close at $0.69 after declining around 9% on Monday.
Guardion Health Sciences, Inc. GHSI surged 47.8% to close at $0.28. Guardion Health Sciences, last month, priced its $11 million public offering.
CooTek (Cayman) Inc. CTK gained 36.2% to settle at $0.3203.
Trevi Therapeutics, Inc. TRVI surged 36.1% to close at $0.8711. Trevi Therapeutics recently announced positive interim analysis results from Phase 2 CANAL trial of Haduvio (nalbuphine ER) in idiopathic pulmonary fibrosis patients (IPF) suffering from chronic cough.
Sky Harbour Group Corporation SKYH gained 30.8% to settle at $15.23.
GWG Holdings, Inc. GWGH jumped 29.4% to close at $5.33.
Avinger, Inc. AVGR jumped 28.3% to settle at $0.3336. Avinger recently reported successful completion of first cases with Lightbox 3 next generation imaging console.
Blonder Tongue Laboratories, Inc. BDR gained 27.9% to close at $0.55. Blonder Tongue Laboratories recently announced next generation DRAKE PEG encoder line.
UserTesting, Inc. USER shares surged 27.3% to settle at $10.59 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY22 EPS and sales guidance above analysts’ estimates.
Mmtec, Inc. MTC gained 26.2% to close at $0.5740.
Oak Street Health Inc OSH jumped 23.5% to close at $21.63. Oak Street reported FY21 revenue of $1.43 billion.
Marker Therapeutics, Inc MRKR gained 22.3% to settle at $0.46.
iQIYI, Inc. IQ shares jumped 21.5% to close at $5.03 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion.
InVivo Therapeutics Holdings Corp. NVIV surged 21.3% to settle at $0.3702.
Stabilis Solutions, Inc SLNG gained 20.8% to close at $5.81.
X4 Pharmaceuticals, Inc. XFOR surged 20% to close at $1.80.
Danimer Scientific Inc DNMR gained 19.9% to close at $4.77 following narrower-than-expected quarterly loss.
Workhorse Group Inc. WKHS surged 19.5% to close at $3.74 after the company reported Q4 results. The company said it expects to sell at least 250 vehicles in 2022 and generate at least $25 million in revenue.
American Rebel Holdings, Inc. AREB jumped 18.8% to close at $1.58. American Rebel recently reported closing of $10.5 million public offering.
Tiziana Life Sciences PLC TLSA gained 18.6% to settle at $0.7710. Tiziana Life Sciences recently highlighted submission of amendment for investigational new drug application to advance oral foralumab for Crohn's Disease.
New Pacific Metals Corp. NEWP jumped 18.6% to close at $3.64. New Pacific Metals, last month, posted Q2 loss of $0.01 per share.
NeuBase Therapeutics, Inc NBSE gained 18.2% to close at $1.75.
Arcimoto, Inc FUV surged 17% to close at $6.88. Arcimoto and Susie's Mopeds, an experience rental company in Friday Harbor, Washington, plan to begin demo rentals of Arcimoto Fun Utility Vehicles on San Juan Island beginning in March.
Ra Medical Systems, Inc.</b> RMED rose 17% to settle at $0.4998. Ra Medical Systems filed 510(k) application for the DABRA catheter with braided overjacket and six-month shelf life.
AnPac Bio-Medical Science Co., Ltd. ANPC surged 16.9% to settle at $0.77.
New Fortress Energy Inc.NFE gained 16.9% to close at $32.25 after the company reported better-than-expected Q4 sales results.
Summit Therapeutics Inc. SMMT gained 16.8% to close at $3.20. Summit Therapeutics recently reported postponement of its planned rights offering.
TaskUs, Inc. TASK gained 16.2% to close at $33.37 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY22 sales guidance above estimates.
LivePerson, Inc. LPSN rose 16% to close at $23.52. Starboard Value raised its stake in LivePerson from 8.5% to 9.7%.
Veritiv Corporation VRTV jumped 15.6% to close at $123.92 after the company posted upbeat quarterly results.
BP Prudhoe Bay Royalty Trust BPT rose 15.4% to close at $14.55 as the Russia-Ukraine conflict caused supply concerns.
Redbox Entertainment Inc. RDBX surged 15.4% to close at $2.17.
Freshpet, Inc.</b> FRPT gained 15.2% to settle at $109.74 after the company issued FY22 sales guidance above analysts’ estimates.
AVITA Medical, Inc. RCEL gained 14.9% to close at $10.57 following Q2 results.
Dogness (International) Corporation DOGZ surged 14.5% to close at $3.24.
Humanigen, Inc. HGEN rose 14.3% to close at $2.32. Humanigen recently reported a FY21 net loss of $4.04 per share.
Quantum-Si Inc QSI gained 13.5% to close at $4.72 following Q4 results.
Cano Health, Inc. CANO rose 9.9% to close at $5.35. Cano Health delayed Q4 earnings release and conference call.
Target Corporation TGT climbed 9.8% to close at $219.43 after the company reported better-than-expected Q4 EPS results and issued FY22 guidance.
Ucommune International Ltd UK shares gained 8.3% to close at $0.4397 after dipping around 17% on Monday.

Check out this: Insiders Sell Around $16M Of 4 Stocks

Losers

Vroom, Inc. VRM dropped 46.6% to settle at $3.25 after the company reported worse-than-expected Q4 EPS results.
Mullen Automotive, Inc. MULN fell 39.1% to close at $1.03 after gaining over 145% on Monday. Mullen Automotive recently announced progress on solid-state polymer battery pack development.
GoodRx Holdings, Inc. GDRX shares tumbled 38.9% to close at $16.74 on Tuesday after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.
Imperial Petroleum Inc. IMPP fell 37.6% to close at $1.48.
Check-Cap Ltd. CHEK dropped 37% to settle at $0.3870 after the company announced a $10 million registered direct offering.
ZimVie Inc. ZIMV dipped 32.8% to close at $25.53. Credit Suisse initiated coverage on ZimVie with an Underperform rating and announced a price target of $34.
Ambarella, Inc. AMBA fell 31.3% to close at $95.98 after the company reported Q4 earnings results and issued guidance.
Semler Scientific, Inc. SMLR dipped 27.9% to close at $52.64 after the company reported Q4 EPS and sales results down from last year.
VEON Ltd. VEON dropped 26.3% to close at $0.38. VEON recently reported Q4 earnings results.
DSS, Inc. DSS shares fell 23.1% to close at $0.4352 after jumping 47% on Monday.
Endo International plc ENDP dropped 22.5% to close at $2.41 after the company reported Q4 earnings results.
Sidus Space, Inc. SIDU fell 22% to close at $4.18.
Atara Biotherapeutics, Inc. ATRA dropped 20.5% to close at $10.21 after the company reported worse-than-expected Q4 EPS results.
Indonesia Energy Corporation Limited INDO dipped 20.2% to settle at $10.78.
Zeta Global Holdings Corp. ZETA fell 19.9% to settle at $10.42.
James River Group Holdings, Ltd. JRVR dropped 19.5% to close at $21.41 after the company reported Q4 EPS results down from last year.
Paya Holdings Inc. PAYA fell 19.5% to close at $5.19 following Q4 results.
China SXT Pharmaceuticals, Inc. SXTC fell 19.5% to close at $0.1730 in pre-market trading after jumping 45% on Monday.
Intellia Therapeutics, Inc. NTLA fell 19.2% to close at $79.85. Eight months after delivering promising biomarker data from one of the first CRISPR trials, Intellia Therapeutics presented additional data from the Phase 1 trial for NTLA-2001 in transthyretin, or ATTR, amyloidosis.
MBIA Inc. MBI dipped 19% to settle at $12.35 after the company reported worse-than-expected Q4 EPS results.
Heron Therapeutics, Inc. HRTX dropped 18.9% to close at $5.76 after the company reported worse-than-expected Q4 sales results.
Core Scientific, Inc. CORZ fell 18.6% to close at $7.49.
NeuroSense Therapeutics Ltd. NRSN dropped 18.1% to close at $2.13. NeuroSense Therapeutics was granted patent for its ALS drug PrimeC in Australia.
Vallon Pharmaceuticals, Inc. VLON dipped 17.6% to close at $6.09. Vallon Pharmaceuticals recently announced issuance of US patent covering ADAIR for treatment of cognitive impairment associated with COVID-19.
Albireo Pharma, Inc. ALBO dropped 17.3% to settle at $27.57 after the company reported Q4 earnings results.
PubMatic, Inc. PUBM shares fell 17.2% to close at $25.35 after the company issued Q1 sales guidance below estimates.
Werewolf Therapeutics, Inc. HOWL dipped 15.9% to close at $6.02.
BigCommerce Holdings, Inc. BIGC fell 15.6% to close at $21.85 after the company reported worse-than-expected Q4 adjusted EPS results and issued guidance.
Kyndryl Holdings, Inc. KD dropped 14.8% to close at $13.50 after the company reported Q4 earnings results and said it sees Q1 sales down roughly 5%.
Ranpak Holdings Corp. PACK fell 14.8% to close at $20.61.
Ranpak recently reported Q4 earnings results.
Amylyx Pharmaceuticals, Inc. AMLX dropped 14.8% to close at $28.04.
eHealth, Inc. EHTH fell 14.6% to close at $13.27 after the company reported worse-than-expected Q4 sales results.
Shift Technologies, Inc. SFT dropped 14.4% to close at $1.73.
CSP Inc. CSPI fell 14.3% to close at $7.07.
International Game Technology PLC IGT dropped 13.9% to close at $26.37 following Q4 results.
Lucid Group, Inc. LCID fell 13.8% to close at $24.99 after the company reported worse-than-expected Q4 sales results and cut FY22 production guidance.
ON24, Inc. ONTF dipped 12.4% to close at $13.67 after the company issued Q1 and FY22 guidance below analyst estimates.
Groupon, Inc. GRPN shares fell 7.7% to close at $20.05 after the company reported worse-than-expected Q4 EPS and sales results and issued Q1 sales guidance below estimates.